UMN expands horizons with new deal for baculovirus flu vaccines
This article was originally published in Scrip
Executive Summary
The privately held Japanese vaccines venture UMN Pharma has struck its second major out-licensing alliance with a pharmaceutical company, awarding Ildong Pharmaceuticals rights in South Korea to three pipeline influenza vaccines.